Luncheon symposium 1 Chair(s): Bon Jeong Ku, Sangyong Kim
Friday 26 September, 12:00~12:15
Room 1
(Vista 1+2, B2F)

LS01-L1
Da Hea SeoInha University, Korea

Benefit of SGLT2 inhibitor combination therapy for the treatment of T2DM

Luncheon symposium 6 Chair(s): Hyun Shik Son, You-Cheol Hwang
Friday 26 September, 12:15~12:30
Room 2
(Vista 3, B2F)

LS06-L1
Seung-Hwan LeeThe Catholic University of Korea, Korea

Initiating DPP-4i/SGLT-2i combination: who, when, and how?

Luncheon symposium 2 Chair(s): Hyun Shik Son, You-Cheol Hwang
Friday 26 September, 12:00~12:15
Room 2
(Vista 3, B2F)

LS02-L1
Soo Heon KwakSeoul National University, Korea

Clinical effects of nsMRA: a new stream in CKD treatment for T2D patients

Luncheon symposium 5 Chair(s): Bon Jeong Ku, Sangyong Kim
Friday 26 September, 12:15~12:30
Room 1
(Vista 1+2, B2F)

LS05-L1
TBDTBD

TBD

Breakfast symposium 1 Chair(s): Hak Chul Jang
Friday 26 September, 08:00~08:20
Room 3
(Walker hall 1, 1F)

BS1-L1
Ja Young JeonAjou University, Korea

Benefit of new prescription for complicated dyslipidemia PTs

Luncheon symposium 3 Chair(s): Jae Myung Yu, Sung Woo Ha
Friday 26 September, 12:00~12:15
Room 3
(Walker hall 1, 1F)

LS03-L1
Chang Hee JungUniversity of Ulsan, Korea

Why SGLT2i comes first for optimal T2D treatment?

Luncheon symposium 7 Chair(s): Jae Myung Yu, Sung Woo Ha
Friday 26 September, 12:15~12:30
Room 3
(Walker hall 1, 1F)

LS07-L1
Jie Eun LeeCHA University, Korea

When and how to start initial combination therapy in T2D

Breakfast symposium 2 Chair(s): Jeong-Taek Woo
Friday 26 September, 08:00~08:20
Room 4
(Walker hall 2, 1F)

BS2-L1
Young Sang LyuChosun University, Korea

TZD+SGLT-2i combination therapy; benefits for diabetix complications and MASLD

Luncheon symposium 4 Chair(s): Ho-Sang Shon, Jong Chul Won
Friday 26 September, 12:00~12:15
Room 4
(Walker hall 2, 1F)

LS04-L1
Jin Hwa KimChosun University, Korea

The benefits of early combination therapies including SGLT2i

Luncheon symposium 8 Chair(s): Ho-Sang Shon, Jong Chul Won
Friday 26 September, 12:15~12:30
Room 4
(Walker hall 2, 1F)

LS08-L1
So Hun KimInha University, Korea

T.E.N-year journey: advanced DPP-4i's decade of excellence in Korean diabetes care

Luncheon symposium 13 Chair(s): In Joo Kim, Hyun Jin Kim
Saturday 27 September, 12:35~12:50
Room 1
(Vista 1+2, B2F)

LS13-L1
Jung Hwan ParkHanyang University, Korea

Is there a better treatment option for dyslipidemia patients with impaired glucose metabolism

Luncheon symposium 9 Chair(s): In Joo Kim, Hyun Jin Kim
Saturday 27 September, 12:20~12:35
Room 1
(Vista 1+2, B2F)

LS09-L1
So Ra KimYonsei University, Korea

Early combination therapy in type 2 diabetes: focus on TZD and SGLT2 inhibitor combinations

Breakfast symposium 3 Chair(s): Yong Wook Cho
Saturday 27 September, 08:00~08:20
Room 2
(Vista 3, B2F)

BS3-L1
Eun Hui BaeChonnam National University, Department of Nephrology, Korea

Dapa.N’s cardiorenal benefits for CKD patients: from mechanistic insights to real-world application

Luncheon symposium 10 Chair(s): Kyung Wan Min, Jin Ook Chung
Saturday 27 September, 12:20~12:35
Room 2
(Vista 3, B2F)

LS10-L1
Tae Jung OhSeoul National University, Korea

The cardio-renal-metabolic vicious cycle: choosing the suitable statin for complex risk profiles

Luncheon symposium 14 Chair(s): Kyung Wan Min, Jin Ook Chung
Saturday 27 September, 12:35~12:50
Room 2
(Vista 3, B2F)

LS14-L1
Jun Hwa HongEulji University, Korea

A new era in type 2 diabetes treatment : surpassing glycemic goal and beyond with GIP/GLP-1RA

Breakfast symposium 4 Chair(s): Hyoungwoo Lee
Saturday 27 September, 08:00~08:20
Room 3
(Walker hall 1, 1F)

BS4-L1
Hae Kyung KimYonsei University, Korea

Ideal combination therapy for T2DM: SGLT-2i&TZD

Luncheon symposium 11 Chair(s): Youngsik Choi, Hyesoon Kim
Saturday 27 September, 12:20~12:35
Room 3
(Walker hall 1, 1F)

LS11-L1
Soo Kyoung KimGyeongsang National University, Korea

Reappraisal of TZD to control diabetes and its complications

Luncheon symposium 15 Chair(s): Youngsik Choi, Hyesoon Kim
Saturday 27 September, 12:35~12:50
Room 3
(Walker hall 1, 1F)

LS15-L1
Yun Kyung ChoUniversity of Ulsan, Korea

Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2D

Breakfast symposium 5 Chair(s): Yu-Bae Ahn
Saturday 27 September, 08:00~08:20
Room 4
(Walker hall 2, 1F)

BS5-L1
Jae-Seung YunThe Catholic University of Korea, Korea

Targeting ASCVD primary prevention in diabetic patients: can cilostazol make a difference?

Luncheon symposium 12 Chair(s): Kyung Ah Han, Seak Ki Yun
Saturday 27 September, 12:20~12:35
Room 4
(Walker hall 2, 1F)

LS12-L1
Gyuri KimSungkyunkwan University, Korea

Importance of timely insulin initiation for better diabetes management: Well-balanced basal insulin between glycemic control & low hypoglycemia risk

Luncheon symposium 16 Chair(s): Kyung Ah Han, Seak Ki Yun
Saturday 27 September, 12:35~12:50
Room 4
(Walker hall 2, 1F)

LS16-L1
Wonjin KimCHA University, Korea

The importance of shingles prevention in the treatment journey of patients with diabetes